Vx-135

[Anonymous]

Any word? Will they be hiring soon for launch?

 

[Anonymous]

Any word? Will they be hiring soon for launch?

LOL! are you serious...um NO

 

[Anonymous]

What's the latest data on vx-135?

 

[Anonymous]

What's the latest data on vx-135?

Data is good, timing is too late. Gilead broke the bank on HepC.

 

[Anonymous]

Data is good, timing is too late. Gilead broke the bank on HepC.

Get a clue. VX-135 has been dead weight for years now...

 

[Anonymous]

Get a clue. VX-135 has been dead weight for years now...

You get a clue! The data is very good. But we need to get things moving a lot faster.

 

[Anonymous]

You get a clue! The data is very good. But we need to get things moving a lot faster.

You really are a fool

 

[Anonymous]

You really are a fool

You're an idiot. Probably the vertex janitor.

 

[Anonymous]

Please see the following article and look at the bottom of the article:

http://investors.vrtx.com/releasedetail.cfm?ReleaseID=844664

It seems that VX-135 is over according to this.

 

[Anonymous]

Hepatitis C

Vertex today announced that it has amended the terms of its agreement with Alios BioPharma regarding the development and commercialization of the nucleotide analogue hepatitis C virus (HCV) polymerase inhibitor VX-135. Based on the revised agreement and the rapid changes in the hepatitis C treatment landscape following the introduction of new oral therapies, Vertex plans to out-license VX-135 and to end further investment into research and development efforts in hepatitis C.

 

[Anonymous]

Hepatitis C

Vertex today announced that it has amended the terms of its agreement with Alios BioPharma regarding the development and commercialization of the nucleotide analogue hepatitis C virus (HCV) polymerase inhibitor VX-135. Based on the revised agreement and the rapid changes in the hepatitis C treatment landscape following the introduction of new oral therapies, Vertex plans to out-license VX-135 and to end further investment into research and development efforts in hepatitis C.

Thanks. And this is a quote from our press release. But there are still too many clueless people in the company who think we are still players in the HCV market. Those fools need to be flushed out. And fast.

 

[Anonymous]

Like many at Vertex, these VX-135 Truthers can't see the forest for the trees. That's why we're going to go down as a company. To many scientists and MDs, not enough business sense and MBAs.

 

[Anonymous]

Truth is vx-135 combined with declatisvir is a great drug. There is still a chance. I guess we'll have to wait and see.

 

[Anonymous]

Truth is vx-135 combined with declatisvir is a great drug. There is still a chance. I guess we'll have to wait and see.

Who's the "we" in "we'll"? Come out of your fairy tale land. Everyone in HCV is being let go.

 

[Anonymous]

Who's the "we" in "we'll"? Come out of your fairy tale land. Everyone in HCV is being let go.

Not if vx-135 is combined with BMS. Which looks likely with CV over at BMS.

 

[Anonymous]

Not if vx-135 is combined with BMS. Which looks likely with CV over at BMS.

A lowly director isn't going to make that happen

 

[Anonymous]

Not if vx-135 is combined with BMS. Which looks likely with CV over at BMS.

Vx=135 is the future. All hail it. BMS is swiftly moving to combine with it. It's all happening quickly. The end is near.

Which of the above is true?